One developer of a weight loss medication, clinical-stage biotech Structure Therapeutics ( GPCR 0.16%), was a victim of a ...
Novo Nordisk's sales and profits were both up around 30% last quarter. Its GLP-1 weight loss drug has been a driving force ...
Food and drug companies have expressed optimism, but the new health secretary and his MAHA movement will likely make waves.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback